Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
Semax (Met-Glu-His-Phe-Pro-Gly-Pro, MW ~813 Da) is a heptapeptide ACTH₄₋₇ analogue that potently upregulates BDNF synthesis in neurons and astrocytes. The sequence of events: Semax binds melanocortin receptors (primaril…
Source: peptideslabuk.comComparison
Primary pathway MC4R→cAMP/CREB→BDNF→TrkB-PI3K-Akt Ctr1→Nrf2→ARE→HO-1/NQO1/GCL; Keap1 oxidation Onset of neuroprotection Delayed: 12–24h for full BDNF-TrkB effect Biphasic: immediate chelation (0–30 min) + Nrf2 (4–8h) Pr…
Source: peptideslabuk.comComparison
The temporal dynamics of neuroprotection differ critically between the two compounds — a difference with direct implications for post-injury intervention timing: Semax temporal profile: MC4R binding → cAMP → CREB-pSer13…
Source: peptideslabuk.comComparison
All peptide compounds referenced in this article are intended strictly for laboratory and academic research purposes. They are not approved for human use, therapeutic application, or clinical treatment. This content is …
Source: peptideslabuk.comComparison
Understanding the various delivery methods for GHK-Cu is crucial for researchers. Each method presents distinct advantages and considerations, particularly when aiming for optimal GHK-Cu for wrinkle reduction results. B…
Source: realpeptides.coComparison
The distinction between GHK-Cu for wrinkles and other peptide classes comes down to mechanism specificity. Palmitoyl pentapeptide-4 (Matrixyl) is marketed as a collagen booster, but its primary documented effect is stim…
Source: realpeptides.coComparison
These three mechanisms approach fine line reduction through completely different pathways, and understanding those differences determines which one works for your specific aging pattern. Primary Action Delivers copper t…
Source: realpeptides.coComparison
Collagen Synthesis TGF-β upregulation, lysyl oxidase activation 18-20% increase in dermal thickness (biopsy-confirmed) 8-12 weeks Most significant benefit for women 25-35; addresses root cause of future structural loss …
Source: realpeptides.coComparison
Purity (peptide) >98% via HPLC 40–85% (manufacturer claim, unverified) Often undisclosed Only research-grade purity guarantees the published mechanism works as intended Copper chelation verification Mass spec confirmed …
Source: realpeptides.coComparison
Pre-formulated serums 0.05–0.5% 6–12 months (unopened) $40–$120 Moderate. Vehicle-dependent Convenient but concentration often subtherapeutic; verify third-party purity testing Lyophilized peptide powder 98%+ pure compo…
Source: realpeptides.coComparison
Topical (non-liposomal) 0.05–0.1% Stratum corneum only Twice daily 12+ weeks Low bioavailability. Requires consistent long-term use for measurable effect Topical (liposomal) Viable epidermis + upper dermis 8–10 weeks Im…
Source: realpeptides.coComparison
Journal of Cosmetic Dermatology (2018) Randomized, vehicle-controlled, N=60 2% topical cream, twice daily 12 weeks Hair density (hairs/cm²) +31.2 hairs/cm² vs +3.1 control p<0.001 Gold-standard design with objective pho…
Source: realpeptides.coComparison
Topical serum (liposomal) 0.5–1.0% GHK-Cu 6–8 weeks (fine lines), 12 weeks (texture) Gradual dermal penetration, sustained low-dose collagen stimulation Requires consistent twice-daily application; results plateau witho…
Source: realpeptides.coComparison
GHK-Cu is one of the few peptides with documented efficacy via both topical and injectable routes, but the mechanisms and outcomes differ meaningfully. Topical application at 1–3% concentration penetrates the stratum co…
Source: realpeptides.coComparison
Topical GHK-Cu formulations typically range from 0.5% to 3% concentration by weight. Clinical efficacy has been demonstrated at 1% concentration applied twice daily over 12 weeks, with biopsy-confirmed increases in derm…
Source: realpeptides.coComparison
GHK-Cu (topical) Copper-dependent collagen synthesis, angiogenesis, TGF-β modulation Small-scale human trials (N=23–30), no FDA approval 5.9% mean hair density increase at 12 weeks (Pickart 2007) Limited direct data. Su…
Source: realpeptides.coComparison
GHK-Cu Copper delivery + collagen synthesis modulation 0.5–3% Limited (small human trials, strong in vitro data) Promising but not yet comparable to retinoid-level evidence. Best positioned as adjunct therapy. Matrixyl …
Source: realpeptides.coComparison
Subcutaneous GHK-Cu administration bypasses the stratum corneum entirely, delivering the peptide directly to dermal fibroblasts at concentrations 10–20× higher than topical application achieves. Injection protocols used…
Source: realpeptides.coComparison
GHK-Cu is available in two delivery formats: topical gels/serums (typically 1–3% concentration) and injectable solutions (0.5–2mg per administration). Topical formulations depend on molecular weight and vehicle formulat…
Source: realpeptides.coComparison
Randomized controlled trial (n=20) 2.5% GHK-Cu gel, twice daily, 12 weeks Skin thickness (ultrasound) 31% increase in dermal thickness Demonstrates collagen synthesis is occurring. Not surface hydration Split-abdomen st…
Source: realpeptides.co